COVID-19 Newsroom

Photo Gallery 

All images are the property of Battelle, and are available to members of the media upon request.
Please contact Katy Delaney or TR Massey for print-quality images.

Fast Facts

• The Battelle Critical Care Decontamination System™ is a self-contained, mobile decontamination system that uses vapor phase hydrogen peroxide (VPHP) to decontaminate N95 respirator masks.
  
  
• Battelle CCDS™ renders SARS-CoV-2 non-infectious on N95 respirators and enables up to 20 reuses without degrading filter performance to help address the current U.S. PPE shortage.
  
  
• The Battelle CCDS™ system is based on published research that Battelle performed for the FDA in 2015. Battelle CCDS™ uses the same decontamination process that was proven effective in this FDA study.
  
  
• Battelle received FDA Emergency Use Authorization for the Battelle CCDS Critical Care Decontamination System™.
  
  
• Each Battelle CCDS™ is designed to decontaminate up to 80,000 N95 respirators per day.
  
  
• The system is scalable and designed for fast deployment to add capacity and to meet demand.
  
  
• Respirator masks are tracked throughout our process with each hospital receiving their own masks back .
  
  
• Battelle CCDS™ is effective against both viral and bacterial agents. Battelle tested VPHP decontamination efficacy against SARS-CoV-2 in our Bio Safety Level 3 (BSL 3) laboratories.
  
  
• Battelle is currently conducting research to validate that other equipment, including surgical masks and ventilator components, can be decontaminated using this process.
  
  
• On March 15, 2020, Battelle started building systems at one of its manufacturing operations in Columbus for shipment to sites around the country.
  
  
• Battelle has a full medical device development team that works with the FDA on a regular basis.
  
  
• Battelle is the largest, private, non-profit research and development organization in the world.